Author

İsmail Zİhnİ

h-index 1 View on Semantic Scholar

We have 3 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Pathologic complete response and residual disease after neoadjuvant chemotherapy in breast cancer: Comparison of contrast-enhanced mammography, DCE-MRI, and ¹⁸F-FDG PET/CT.

Accurate assessment of breast cancer response to neoadjuvant chemotherapy (NAC) is important for surgical planning. We compared contrast-enhanced mammography (CEM), dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FD...

Ebru Özan Sanhal, İmren Mutlu, Evrim Sürer Budak et al. · Biomolecules & biomedicine · 0 citations

Open access Aug 2026

Circulatory and other-cause mortality after neoadjuvant versus adjuvant chemotherapy in women with stage II-III breast cancer.

In older long-term breast-cancer survivors, late mortality is predominantly multimorbid rather than circulatory-dominant, supporting survivorship care that addresses cardiovascular risk within a broader framework of age-related competing health risks.

Burcu Zihni, İsmail Zİhnİ, M. Z. Sabuncuoğlu · Biomolecules & biomedicine · 0 citations

Open access Jul 2026

Cardiovascular versus breast cancer mortality in men with breast cancer: An age-stratified SEER competing-risk study.

In men with non-metastatic breast cancer, cardiovascular cumulative incidence overtakes that of breast cancer early after diagnosis in the oldest patients, which support age-aware cardiovascular attention during survivorship but do not establish that intensified cardiovascular surveillance improves outcomes.

İsmail Zİhnİ, Burcu Zihni, M. Z. Sabuncuoğlu · Biomolecules & biomedicine · 0 citations